Evidence map›Paper›PMID 19664266›Full record

ArticleHealth and quality of life outcomes2009

Utility of WHOQOL-BREF in measuring quality of life in sickle cell disease.

Monika R Asnani, Garth E Lipps, Marvin E Reid

Registry-linked trialAbstract readValidation Study
In one paragraph

Article in Health and quality of life outcomes, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04810572 (Evaluation of the Effects of a Nutraceutical Composition Containing Derivatives From Natural Products on the Modulation of the Endocrine Neuroimmune Axis - Translational Study.), which is not on this map. Cited by 21 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04810572 nacompletednot on this mapstarted 2021, after this paper: background citation

Evaluation of the Effects of a Nutraceutical Composition Containing Derivatives From Natural Products on the Modulation of the Endocrine Neuroimmune Axis - Translational Study.

TypeinterventionalSponsorUniversity of Sao Paulo General HospitalRan2021 to 2022Enrolled162ConditionsInsulin Resistance, Inflammatory Bowel Diseases, Overweight and Obesity, HealthyArmsComposition with Silymarin, Low-mineral composition without Silymarin
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Interventions for treating leg ulcers in people with sickle cell disease.The Cochrane database of systematic reviews · 2021
    Pooled it
  4. Interventions for treating leg ulcers in people with sickle cell disease.The Cochrane database of systematic reviews · 2014
    Pooled it
  5. Trial
  6. WHOQOL-BREF in Measuring Quality of Life Among Sickle Cell Disease Patients with Leg Ulcers.International journal of environmental research and public health · 2025
    Article
  7. Article
  8. Quality of life among Syrian refugees in Germany: a cross-sectional pilot study.Archives of public health = Archives belges de sante publique · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Tooth loss and general quality of life in dentate adults from Southern Brazil.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Application of WHOQOL-BREF in Measuring Quality of Life in Health-Care Staff.International journal of preventive medicine · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Monika R AsnaniSickle Cell Unit, Tropical Medicine Research Institute, University of the West Indies, Mona Campus, Kingston 7, Jamaica. monika.parshadasnani@uwimona.edu.jm
Garth E Lipps
Marvin E Reid

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSickle cell disease is the commonest genetic disorder in Jamaica and most likely exerts numerous effects on quality of life (QOL) of those afflicted with it. The WHOQOL-Bref, which is a commonly utilized generic measure of quality of life, has never previously been utilized in this population. We have sought to study its utility in this disease population.

methods491 patients with sickle cell disease were administered the questionnaire including demographics, WHOQOL-Bref, Short Form-36 (SF-36), Flanagan's quality of life scale (QOLS) and measures of disease severity at their routine health maintenance visits to the sickle cell unit. Internal consistency reliabilities, construct validity and "known groups" validity of the WHOQOL-Bref, and its domains, were examined; and then compared to those of the other instruments.

resultsAll three instruments had good internal consistency, ranging from 0.70 to 0.93 for the WHOQOL-Bref (except the 'social relationships' domain), 0.86-0.93 for the SF-36 and 0.88 for the QOLS. None of the instruments showed any marked floor or ceiling effects except the SF-36 'physical health' and 'role limitations' domains. The WHOQOL-Bref scale also had moderate concurrent validity and showed strong "known groups" validity.

conclusionThis study has shown good psychometric properties of the WHOQOL-Bref instrument in determining QOL of those with sickle cell disease. Its utility in this regard is comparable to that of the SF-36 and QOLS.

Indexed as

Anemia, Sickle CellQuality of LifeAdolescentAdultAgedFemaleHumansJamaicaMaleMiddle AgedSurveys and QuestionnairesYoung Adult

Identifiers

PMID19664266
PMCPMC2736920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.